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Hepatic hemangioma patients with Kasabach-Merritt syndrome have reportedly been cured by liver transplantation.
However, liver transplantation as a potential cure for a stable patient without Kasabach-Merritt syndrome remains
debatable. We report the case of a 27-year-old female patient with a giant hepatic hemangioma. The hemangioma
measured 50 × 40 × 25 cm in size and weighed 15 kg, which is the largest and heaviest hemangioma reported in
the literature. The patient showed jaundice, ascites, anemia, and appetite loss; but no disseminated intravascular
coagulation was observed through laboratory findings. We successfully operated using a right lobe graft without
the middle hepatic vein from a 55-year-old donor. At the long-term follow-up, the patient experienced two acute
rejections, which were confirmed by biopsy. However, the patient still survives with good graft function after
50 months.
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Hepatic hemangiomas are the most commonly occurring
benign tumors of the liver. These tumors often remain
asymptomatic when their diameter is smaller than 4 cm
[1]. The available treatment options include radiation,
interferon therapy, and embolization [1]. Surgical resec-
tion is the most common treatment modality [2]. A stable
hemangioma has a rupture rate of 1% to 4% and a fatality
rate of 60% to 75% after rupture. Kasabach-Merritt
syndrome is characterized by the occurrence of dissemi-
nated intravascular coagulation that results from a hepatic
hemangioma, and has a fatality rate of 10% to 37% that
rises to 80% in the first year [3]. It has been reported that
hepatic hemangioma patients with Kasabach-Merritt syn-
drome have been cured by liver transplantation [4,5].
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reproduction in any medium, provided the or40 × 25 cm in size and weighing 15 kg; this is the largest
and heaviest hemangioma reported in the literature
[6,7]. Patients with a high Model for End-stage Liver
Disease (MELD) score caused by Kasabach-Merritt syn-
drome or with a ruptured tumor are eligible for receiv-
ing organs from the cadaveric donor pool. However, the
progress of a stable hemangioma can cause abnormal
coagulation mechanisms or hemangioma rupture, which
results in the loss of opportunity for operation or in-
creased operation risk. Living donor liver transplantation
is therefore the best option in these cases. This surgical
method thus solves the problem of the source of the
graft, and possesses a high level of safety. The imple-
mentation of this method may determine the progress of
the operation and the nature of the outcome. In this
case, the patient received a living donor liver transplant-
ation for a giant hepatic hemangioma using a right lobe
graft without the middle hepatic vein (MHV) [8].Case presentation
A 27-year-old female patient, who experienced upper ab-
dominal pain and progressive hepatoma for 4 years, was
diagnosed with a giant hepatic hemangioma. The patientLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 2 The giant hemangioma during surgery, approximately
50 × 40 × 25 cm in size.
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varicose veins on presentation. Laboratory examination
showed a hemoglobin level of 81 g/L and a platelet count
of 95 × 109/L. Blood biochemistry showed total bilirubin
concentration of 1.34 mg/dL, alanine aminotransferase
concentration of 10 U/L, and creatinine level of 0.44
mg/dL. The coagulation tests showed a prothrombin time
(PT) of 15.4 seconds, activated partial thromboplastin
time of 35 seconds, fibrinogen concentration of 4.2 g/L,
and fibrinogen degradation product tests were negative.
An abdominal CT scan indicated the presence of low-
density areas in both the liver lobes, occupying the entire
abdominal cavity without rupture (Figure 1). The recipient
was further examined and this revealed a hemangioma oc-
cupying the entire abdominal cavity, measuring approxi-
mately 50 × 40 × 25 cm in size (Figure 2).
Surgery was performed on September 1, 2007. The
donor was the patient’s 55-year-old father. Preoperative
evaluation showed that the graft-to-recipient weight ra-
tio (GRWR) was 1.46% and the remnant liver volume
(RLV) of the donor was 47%. During surgery, the liverFigure 1 CT scan shows the giant hepatic hemangioma occupying the entire abdominal cavity.
Figure 3 The donor’s V8 segment vein bridging to the inferior
vena cava with good blood reflux.
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hemangioma rupture. We ligated the portal canal and
blocked the upper and lower blood supply to the liver,
and then resected the recipient’s liver and simultan-
eously preserved the donor’s inferior vena cava. A hep-
atic occlusion clamp was used to control the blood flow
to the liver from the inferior vena cava. End-to-end
anastomosis was performed in order to join theFigure 4 The donor’s hepatic artery and hepatic vein; the arrow showrecipient’s right hepatic vein and the donor’s right hep-
atic vein. The diameter of the V8 segment vein was
0.3 cm. We dealt with the inferior mesenteric vein by
bridging the inferior vena cava to avoid congestion of
the V8 segment vein (Figures 3 and 4). End-to-end anas-
tomosis was also performed between the donor and re-
cipient’s right branch of the portal vein, as well as for
the donor’s and recipient’s common hepatic veins. The
hepatic artery, portal vein, and bile duct was resected
using the anterior approach. The portal vein was cut
using the 55-mm cutting stapler (Johnson & Johnson) to
avoid the effects of using a surgical clamp on the portal
vein. In situ incision of the coronary ligament and deltoid
ligament was performed to separate the hepatogastric liga-
ment for the left side of the liver. Finally, 3 to 5 hepatic
segment veins were ligated and incised along the hepatic
inferior vena cava in the centripetal direction and the dis-
eased liver was resected without moving the right liver
lobe with retention of the retro-hepatic inferior vena cava.
A variation in the donor’s bile duct was observed and
dealt with surgically. The right anterior branch was con-
nected to the left hepatic duct, which was clearly visible
on bile duct radiography of the graft (Figure 5). The
right anterior branch and the posterior branch were
anastomosed to a single orifice.s the V8 segment vein.
Figure 5 Variation observed in the bile duct. The right anterior
branch imported into left hepatic duct. Right anterior branch and
posterior branch were reconstructed into a single orifice that was
anastomosed to the common hepatic duct of the recipient.
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transfusion of any blood products. The donor’s surgical
time was approximately 3 hours and 10 minutes (the
time spent on hepatectomy was 2 hours, excluding the
initial abdominal entry and subsequent closure) and that
of the recipient was approximately 4 and a half hours.
The patient recovered gradually after operation without
experiencing any infection or any vascular or biliary
complications. She was discharged 20 days after surgery.
Postoperative pathology showed that the surface of the
removed liver was an abnormal color ranging from gray-
red to gray-yellow. A cross-sectional sample that was ob-
tained was also gray-yellow in color. The entire liver
comprised of tumorous tissue, with little normal hepaticFigure 6 Showing the four important indices of the patient. Two acut
were confirmed by biopsy. The single arrow indicates the first rejection and
reflect these two episodes.tissue remaining. A giant hepatic cavernous hemangioma
was diagnosed. The immunity class showed CD34 (+).
A liver biopsy 12 months after the operation con-
firmed an acute rejection reaction with a Buffer score of
9, but the patient recovered with methylprednisolone
treatment. The second episode of rejection occurred at
17 months with a Buffer score of 7 and was treated by
increasing the tacrolimus dosage and concentration. The
patient currently remains healthy, and the graft is fully
functional.
Discussion
Hepatic hemangiomas are the most common hepatic tu-
mors. The indications for liver transplantation in cases
of hepatic hemangioma include acute and chronic hep-
atic failure, such as occurrence of Kasabach-Merritt syn-
drome, giant hepatic hemangioma affecting the normal
liver tissue eventually causing liver dysfunction, and a
life-threatening giant hepatic hemangioma that cannot
be resected [9,10]. In this case, the patient’s hemangioma
was very large as previously measured and described,
but the patient was stable without Kasabach-Merritt syn-
drome or liver dysfunction. She did experience abdominal
symptoms and showed an extended PT, as well as de-
creased platelet and hemoglobin levels. The risk of
hemangioma rupture was present. If the patient was to
wait for a rupture or a high MELD score in order to be eli-
gible for receiving an organ from the cadaveric donor pool,
the opportunity for surgery would have been lost or the
transplantation risk would have been higher than before.
Therefore, we decided to perform liver transplantation
using a right lobe graft from the patient’s father, and thus,e rejection reactions occurred at 12 months and 17 months, which
the double-arrows indicate the second. The two peaks from the table
Zhong et al. World Journal of Surgical Oncology 2014, 12:83 Page 5 of 6
http://www.wjso.com/content/12/1/83avoided the risk associated with an emergency surgery, en-
suring increased safety associated with such a surgery.
It has been reported that reconstruction is indicated
when the V8 diameter is greater than 5 mm [11]. How-
ever, in our experience, any blood vessels with a diam-
eter greater than 2 mm should be reconstructed. In this
particular case, even though the GRWR was 1.46%, the
size of the donor liver was taken into consideration, and
pre-operative tests have shown that the V8 accounted
for 15% of the blood reflow in the donor liver. The im-
mediate post-operative blood flow was greater than
260 mL/min and the venous pressure was increased.
These factors increased the risk for small-for-size liver
syndrome. From our observations, patients with GRWR
>1.0 are also at higher risk of developing small-for-size
liver syndrome due to increased venous pressure. Fur-
ther, when the portal vein pressure is greater than
30 mmHg and the right half of the liver, excluding the
hepatic vein, is used, congestion around the midline of
the liver near V5 and V8 can result if the hepatic vein is
not reconstructed. Therefore, reconstruction of the hep-
atic vein can decrease the amount of congestion. Finally,
due to the liver donor being above 55 years old, there was
mild hepatic lipidosis and fibrosis in the donor liver, de-
creasing the ability of the donor liver to recover post-
transplantation. Reconstructing the V8 can aid recovery of
the hepatocytes, thus preventing small-for-size liver syn-
drome. Preoperative evaluation in cases of living donor
liver transplantation is important. In general, a GRWR of
>0.8% and a donor RLV of >40% are two important pa-
rameters [4]. The values of these two vital parameters in
this case were 1.46% and 47%, respectively, thus guaran-
teeing the safety of both donor and recipient.
Outflow impairment of the hepatic vein after surgical
transplantation, also known as small-for-size syndrome,
is a common problem [12]. We used the right lobe graft
without the MHV as the donor organ. The diameter of
the V8 segment vein was 0.3 cm, which could drain suf-
ficient blood to avoid the risk of small-for-size syn-
drome. As mentioned previously, a variation in the
donor’s bile duct was found and dealt with by connect-
ing the right anterior branch to the left hepatic duct,
which was clearly visible on bile duct radiography of the
graft. The reported rate of biliary complications in pa-
tients with such variations ranges from 25% to 35%, and
is high in living donor liver transplant recipients [13-15].
To address this problem, we reconstructed the right an-
terior branch and posterior branch into a single orifice
that was anastomosed to the common hepatic duct of
the recipient.
There are few long-term reports on the outcome of
liver transplantation for a giant hepatic hemangioma.
We have continued follow-ups with this patient for
50 months. The graft functions well, without biliarycomplications or hemangioma recurrence. As described
earlier, two occasions of acute rejection were diagnosed
and treated successfully (Figure 6).
It is thought that the age of the donor and the risk of
rejection might be related. According to previous re-
ports, an older donor presents a higher rejection risk.
However, other researchers believe that there is no ap-
parent difference in the rejection rate and survival rate
of those receiving grafts from older donors [16]. As a re-
sult, the safety and rejection risk associated with older
donors requires more research and discussion.
Conclusions
In summary, we believe that liver transplantation should be
performed early for an unresected giant diffuse hemangioma.
In our experience, a good long-term outcome can be ex-
pected following liver transplantation using a right lobe
graft without the MHV.
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